With a few exceptions, regular consumption will probably do you no
good
Some 20-30% of the population in developed countries take a
daily vitamin supplement. Does it do them any good? Our current
estimates of vitamin requirements are based on the amounts needed to
prevent deficiency diseases; in most countries deficiency is no longer
a major problem. The question is whether higher levels of intake
provide health benefits. There are two ways to answer this question: to
identify biomarkers of optimum nutritional status, rather than the
absence of deficiency; or epidemiological studies to identify nutrients
associated with a lower incidence of chronic diseases, followed by
intervention studies. Neither approach has yet provided satisfactory
answers, and a recent review finds little convincing evidence in favour
of
supplements.1
Shopping to buy health - demand for vitamins is growing in the
middle-aged
GENE J PUSKAR/AP PHOTO
A number of promising suggestions for biomarkers exist,
including metabolic markers of damage from radicals, immune responses,
and damage to DNA. None is responsive to only a single nutrient, and
all are affected by a plethora of non-nutritional
factors.2
3 To
date we do not have any markers that can be used to determine optimum
intakes.
The
epidemiological approach has prompted a number of intervention trials,
most of which have been disappointing. There is clear epidemiological
evidence that people with a high plasma concentration of vitamin E are
less at risk from cardiovascular disease. The Cambridge heart
antioxidant study showed a reduction in non-fatal but not in
fatal myocardial
infarctions.4
While the benefits from reducing non-fatal infarctions are
obvious, this is hardly convincing evidence of the benefits of vitamin
E
supplementation.
Similarly,
there is evidence that high intakes of &bgr; carotene are associated
with lower incidence of lung, prostate, and other cancers, although
&bgr; carotene may simply be a marker of fruit and vegetable
consumption. Carotenes are antioxidants and might be expected to reduce
the damage from radicals that underlies the development of cancer and
cardiovascular disease. However, most compounds that act as
antioxidants do so by forming stable radicals that persist long enough
to undergo metabolism to non-radical compounds. By definition
they therefore form radicals that can penetrate deeper into tissues and
plasma lipoproteins, and potentially cause more damage than the oxygen
radicals they have replaced. The results of two major intervention
studies with &bgr; carotene, one in Finland among smokers and the other
in the United States among people who had been exposed to asbestos,
yielded unexpected and unwanted results: more people receiving the
supposedly protective supplements died from lung (and other)
cancer than people receiving
placebo.5
Vitamin
C is an antioxidant, and it also inhibits the formation of carcinogenic
nitrosamines from dietary amines and nitrites. It might therefore be
expected to have protective action against the development of cancer
and cardiovascular disease. The evidence with respect to cardiovascular
disease is
unconvincing.1
The epidemiological evidence linking a high intake of vitamin C with
reduced cancer incidence is confounded by the fact that the fruits and
vegetables that are sources of vitamin C are also rich in a variety of
other compounds that may be protective. There is a long held belief
that vitamin C (perhaps in very large amounts) is protective against
the common cold. A systematic review did not support this but did find
some evidence of a modest benefit in reducing the duration of symptoms
of
colds.7
An intake of vitamin D above what can be obtained from
normal diets (possibly in combination with supplementary calcium)
delays the loss of bone with increasing age, so supplements may be
advisable to prevent osteoporosis and
osteomalacia.8
For most people, increased exposure to sunlight is probably more
effective than supplements, although we may have to balance the
beneficial effects on bone health against the increased risk of skin
cancer.
The benefits of folic acid
supplements taken periconceptually in preventing neural tube defect
have been shown
convincingly.9
High intakes of folic acid also reduce plasma homocysteine, a risk
factor for cardiovascular disease independent of plasma lipids and
other risk factors, and low intakes of folic acid are associated with
increased risk of colorectal
cancer.10
This has led to mandatory fortification of cereal products in the
United States and elsewhere. However, although folic acid lowers plasma
homocysteine, there is no evidence yet from controlled trials whether
or not this will reduce cardiovascular disease or cancer. Until the
results of intervention trials in progress are available, the benefits
of folic acid supplements other than to prevent neural tube defects
remain
unproved.12
The answer to the question of whether we should take a
multivitamin tablet every day must be that unless our intake is
inadequate as a result of a poor diet then supplements will probably do
us no goodapart from folic acid taken periconceptually and,
possibly, vitamin D by elderly
people.